N/A
N=44
Pilot Testing of a Behavioral Intervention for Chronic Pain in Individuals With HIV
Chronic Pain
Bottom Line
View on ClinicalTrials.gov: NCT02824562 ↗Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcome: Primary: Intervention Feasibility: Median Number of Study Intervention Sessions Attended by Participants — 9 Study Sessions
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Intervention (Behavioral); Control (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Pittsburgh
- Primary completion
- Jun 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intervention Feasibility: Median Number of Study Intervention Sessions Attended by Participants |
9 | — |
| SECONDARY Outcome Assessment Feasibility: Number (Percentage) of Participants Who Complete Outcome Assessments Within One Month |
19; 17; 3; 5 | — |
Summary
Due to its specific pathophysiology and impact on health outcomes, the Institute of Medicine has described chronic pain as a complex chronic disease and a "national public health crisis." The unique neurobiological basis and psychosocial context of chronic pain in HIV-infected patients underscores the importance of developing and testing a behavioral intervention specifically tailored to this population. This study will pilot test a newly-developed behavioral intervention for chronic pain tailored to individuals with HIV.
Eligibility Criteria
Inclusion Criteria
- Enrolled in the Center for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort
- Age ≥ 18 years
- Chronic pain (Brief Chronic Pain Screening Questionnaire (BCPQ) = at least moderate pain for at least 3 months)
- Moderately severe and impairing chronic pain (PEG pain questionnaire = average of all three times is 4 or greater)
Exclusion Criteria
- Do not speak or understand English
- Are planning a new pain treatment like surgery
- Cannot attend the group sessions.
Data sourced from ClinicalTrials.gov (NCT02824562). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.